Heidelberg Pharma AG: Partner RedHill Announces Orphan Drug Designation for MESUPRON
- PDF File: images/files/press-releases-and-ad-hoc-announcements/20171026_heidelberg-pharma_pr_redhill_mesupron_orphandrugdesignation_eng_final.pdf
- Datum: Thursday, 26 October 2017 12:52
- Erstellt am .
- Geändert am .
- Aufrufe: 1329